These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

902 related articles for article (PubMed ID: 30894319)

  • 21. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY COMPREHENSIVE CLINICAL PRACTICE GUIDELINES FOR MEDICAL CARE OF PATIENTS WITH OBESITY.
    Garvey WT; Mechanick JI; Brett EM; Garber AJ; Hurley DL; Jastreboff AM; Nadolsky K; Pessah-Pollack R; Plodkowski R;
    Endocr Pract; 2016 Jul; 22 Suppl 3():1-203. PubMed ID: 27219496
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Statin Use in Primary Prevention of Atherosclerotic Cardiovascular Disease According to 5 Major Guidelines for Sensitivity, Specificity, and Number Needed to Treat.
    Mortensen MB; Nordestgaard BG
    JAMA Cardiol; 2019 Nov; 4(11):1131-1138. PubMed ID: 31577339
    [TBL] [Abstract][Full Text] [Related]  

  • 23. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Grundy SM; Stone NJ; Bailey AL; Beam C; Birtcher KK; Blumenthal RS; Braun LT; de Ferranti S; Faiella-Tommasino J; Forman DE; Goldberg R; Heidenreich PA; Hlatky MA; Jones DW; Lloyd-Jones D; Lopez-Pajares N; Ndumele CE; Orringer CE; Peralta CA; Saseen JJ; Smith SC; Sperling L; Virani SS; Yeboah J
    Circulation; 2019 Jun; 139(25):e1046-e1081. PubMed ID: 30565953
    [No Abstract]   [Full Text] [Related]  

  • 24. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
    Grundy SM; Stone NJ; Bailey AL; Beam C; Birtcher KK; Blumenthal RS; Braun LT; de Ferranti S; Faiella-Tommasino J; Forman DE; Goldberg R; Heidenreich PA; Hlatky MA; Jones DW; Lloyd-Jones D; Lopez-Pajares N; Ndumele CE; Orringer CE; Peralta CA; Saseen JJ; Smith SC; Sperling L; Virani SS; Yeboah J
    J Am Coll Cardiol; 2019 Jun; 73(24):3168-3209. PubMed ID: 30423391
    [No Abstract]   [Full Text] [Related]  

  • 25. Cardiovascular Disease and Mortality in Adults Aged ≥60 Years According to Recommendations by the American College of Cardiology/American Heart Association and American College of Physicians/American Academy of Family Physicians.
    Jaeger BC; Anstey DE; Bress AP; Booth JN; Butler M; Clark D; Howard G; Kalinowski J; Long DL; Ogedegbe G; Plante TB; Shimbo D; Sims M; Supiano MA; Whelton PK; Muntner P
    Hypertension; 2019 Feb; 73(2):327-334. PubMed ID: 30595115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. American College of Cardiology/American Heart Association (ACC/AHA) Class I Guidelines for the Treatment of Cholesterol to Reduce Atherosclerotic Cardiovascular Risk: Implications for US Hispanics/Latinos Based on Findings From the Hispanic Community Health Study/Study of Latinos (HCHS/SOL).
    Qureshi WT; Kaplan RC; Swett K; Burke G; Daviglus M; Jung M; Talavera GA; Chirinos DA; Reina SA; Davis S; Rodriguez CJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28495699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.
    Eckel RH; Jakicic JM; Ard JD; de Jesus JM; Houston Miller N; Hubbard VS; Lee IM; Lichtenstein AH; Loria CM; Millen BE; Nonas CA; Sacks FM; Smith SC; Svetkey LP; Wadden TA; Yanovski SZ; Kendall KA; Morgan LC; Trisolini MG; Velasco G; Wnek J; Anderson JL; Halperin JL; Albert NM; Bozkurt B; Brindis RG; Curtis LH; DeMets D; Hochman JS; Kovacs RJ; Ohman EM; Pressler SJ; Sellke FW; Shen WK; Smith SC; Tomaselli GF;
    Circulation; 2014 Jun; 129(25 Suppl 2):S76-99. PubMed ID: 24222015
    [No Abstract]   [Full Text] [Related]  

  • 28. Atherosclerotic cardiovascular disease risk assessment and predictors of statin use in Filipino-American Women.
    Borja-Hart N; Graff JC; Nolan VG; Wang J; Cooper-DeHoff RM; Ancheta IB
    J Clin Pharm Ther; 2019 Aug; 44(4):632-639. PubMed ID: 30963623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY GUIDELINES FOR MANAGEMENT OF DYSLIPIDEMIA AND PREVENTION OF CARDIOVASCULAR DISEASE - EXECUTIVE SUMMARY
    Jellinger PS; Handelsman Y; Rosenblit PD; Bloomgarden ZT; Fonseca VA; Garber AJ; Grunberger G; Guerin CK; Bell DSH; Mechanick JI; Pessah-Pollack R; Wyne K; Smith D; Brinton EA; Fazio S; Davidson M; Zangeneh F; Bush MA
    Endocr Pract; 2017 Apr; 23(4):479-497. PubMed ID: 28156151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of ACC/AHA and ESC Guideline Recommendations Following Trial Evidence for Statin Use in Primary Prevention of Cardiovascular Disease: Results From the Population-Based Rotterdam Study.
    Pavlovic J; Greenland P; Deckers JW; Brugts JJ; Kavousi M; Dhana K; Ikram MA; Hofman A; Stricker BH; Franco OH; Leening MJ
    JAMA Cardiol; 2016 Sep; 1(6):708-13. PubMed ID: 27439175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 2010 Canadian Hypertension Education Program recommendations for the management of hypertension: part 2 - therapy.
    Hackam DG; Khan NA; Hemmelgarn BR; Rabkin SW; Touyz RM; Campbell NR; Padwal R; Campbell TS; Lindsay MP; Hill MD; Quinn RR; Mahon JL; Herman RJ; Schiffrin EL; Ruzicka M; Larochelle P; Feldman RD; Lebel M; Poirier L; Arnold JM; Moe GW; Howlett JG; Trudeau L; Bacon SL; Petrella RJ; Milot A; Stone JA; Drouin D; Boulanger JM; Sharma M; Hamet P; Fodor G; Dresser GK; Carruthers SG; Pylypchuk G; Burgess ED; Burns KD; Vallée M; Prasad GV; Gilbert RE; Leiter LA; Jones C; Ogilvie RI; Woo V; McFarlane PA; Hegele RA; Tobe SW;
    Can J Cardiol; 2010 May; 26(5):249-58. PubMed ID: 20485689
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implications of the new American College of Cardiology/American Heart Association cholesterol guidelines for primary atherosclerotic cardiovascular disease event prevention in a multi ethnic cohort: Multi-Ethnic Study of Atherosclerosis (MESA).
    Yeboah J; Sillau S; Delaney JC; Blaha MJ; Michos ED; Young R; Qureshi WT; McClelland R; Burke GL; Psaty BM; Herrington DM
    Am Heart J; 2015 Mar; 169(3):387-395.e3. PubMed ID: 25728729
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessing gaps in cholesterol treatment guidelines for primary prevention of cardiovascular disease based on available randomised clinical trial evidence: The Rotterdam Study.
    Pavlović J; Greenland P; Deckers JW; Kavousi M; Hofman A; Ikram MA; Franco OH; Leening MJ
    Eur J Prev Cardiol; 2018 Mar; 25(4):420-431. PubMed ID: 29171772
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiovascular Risk and Statin Eligibility in Primary Prevention: A Comparison between the Brazilian and the AHA/ACC Guidelines.
    Cesena FHY; Valente VA; Santos RD; Bittencourt MS
    Arq Bras Cardiol; 2020 Sep; 115(3):440-449. PubMed ID: 33027365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of chronic CAD--do the guidelines (ESC, AHA) reflect daily practice?
    Tillmanns H; Erdogan A; Sedding D
    Herz; 2009 Feb; 34(1):39-54. PubMed ID: 19214408
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Initiation Patterns of Statins in the 2 Years After Release of the 2013 American College of Cardiology/American Heart Association (ACC/AHA) Cholesterol Management Guideline in a Large US Health Plan.
    Olufade T; Zhou S; Anzalone D; Kern DM; Tunceli O; Cziraky MJ; Willey VJ
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28473405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Real-life evaluation of European and American high-risk strategies for primary prevention of cardiovascular disease in patients with first myocardial infarction.
    Mortensen MB; Falk E
    BMJ Open; 2014 Oct; 4(10):e005991. PubMed ID: 25326211
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A summary and critical assessment of the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: filling the gaps.
    Lopez-Jimenez F; Simha V; Thomas RJ; Allison TG; Basu A; Fernandes R; Hurst RT; Kopecky SL; Kullo IJ; Mulvagh SL; Thompson WG; Trejo-Gutierrez JF; Wright RS
    Mayo Clin Proc; 2014 Sep; 89(9):1257-78. PubMed ID: 25131697
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Primary Prevention Using Cholesterol-Lowering Medications in Patients Meeting New Treatment Guidelines: A Retrospective Cohort Analysis.
    Han X; Fox DS; Chu M; Dougherty JS; McCombs J
    J Manag Care Spec Pharm; 2018 Nov; 24(11):1078-1085. PubMed ID: 30362921
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Major Global Coronary Artery Calcium Guidelines.
    Golub IS; Termeie OG; Kristo S; Schroeder LP; Lakshmanan S; Shafter AM; Hussein L; Verghese D; Aldana-Bitar J; Manubolu VS; Budoff MJ
    JACC Cardiovasc Imaging; 2023 Jan; 16(1):98-117. PubMed ID: 36599573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.